Tag: Biogen
Biogen-Denali Parkinson’s Drug Fails Phase 2 Trial, Highlighting Treatment Development Challenges
Biogen and Denali's experimental Parkinson's therapy failed Phase 2 trial endpoints, highlighting ongoing challenges in neurodegenerative disease drug development. The…
Submit Your Paper to GMJ
No APC until January 2027.